DS-7423
CAS No. 1222104-37-1
DS-7423( DS7423 | DS 7423 )
Catalog No. M10844 CAS No. 1222104-37-1
DS-7423 is a novel potent, small-molecule dual inhibitor of PI3K/mTOR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 335 | Get Quote |
|
| 10MG | 500 | Get Quote |
|
| 25MG | 806 | Get Quote |
|
| 50MG | 1098 | Get Quote |
|
| 100MG | 1485 | Get Quote |
|
| 500MG | 2961 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDS-7423
-
NoteResearch use only, not for human use.
-
Brief DescriptionDS-7423 is a novel potent, small-molecule dual inhibitor of PI3K/mTOR.
-
DescriptionDS-7423 is a novel potent, small-molecule dual inhibitor of PI3K/mTOR with IC50 of 15.6, 1143, 249, 262 and 34.9 nM for PI3Kα, PI3Kβ, PI3Kγ, PI3Kδ, and mTOR respectively; exerts anti-tumor effect against a panel of nine OCCA cell lines with IC50 of <75 nM, regardless of the mutational status of PIK3CA; suppresses the tumor growth of OCCA in a dose-dependent manner in mouse xenograft models.Solid Tumors Phase 1 Discontinued.
-
In VitroDS-7423 increases TP53 expression, the level of p-TP53 on Ser-46, and induced apoptosisrelated TP53 target genes (TP53AIP1 and PUMA) in OCCC cells.DS-7423 also inhibits other isoforms of class I PI3K (IC50 values: PI3Kβ = 1,143 nM; PI3Kγ = 249 nM; PI3Kδ = 262 nM).
-
In Vivo——
-
SynonymsDS7423 | DS 7423
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number1222104-37-1
-
Formula Weight520.52
-
Molecular FormulaC22H27F3N10O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (192.12 mM)
-
SMILES——
-
Chemical Name(R)-1-(4-(2-(2-aminopyrimidin-5-yl)-6-morpholino-9-(2,2,2-trifluoroethyl)-9H-purin-8-yl)-2-methylpiperazin-1-yl)ethan-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Koul D, et al. Oncotarget. 2017 Mar 28;8(13):21741-21753.
2. Kashiyama T, et al. PLoS One. 2014 Feb 4;9(2):e87220.
molnova catalog
related products
-
NSC5844
NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
-
GSK-2636771
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
-
IPI-3063
IPI-3063 is an effective and selective inhibitor of PI3K p110δ (IC50: 2.5?±?1.2 nM).
Cart
sales@molnova.com